查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1890960

溶菌酶市场依治疗用途、产品类型、剂型、给药途径、製剂类型、最终用户、通路及地区划分

Lysozyme Market, By Therapeutic Application, By Product Type, By Form, By Route of Administration, By Formulation Type, By End User, By Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3个工作天内

价格
简介目录

溶菌酶市场预计在 2025 年达到 6.059 亿美元，预计到 2032 年将达到 9.922 亿美元，2025 年至 2032 年的复合年增长率为 7.3%。

报告覆盖范围 报告详情
基准年： 2024 2025年市场规模： 6.059亿美元
历史数据时期： 2020-2024 预测期： 2025-2032
预测期间（2025-2032年）： 7.30% 2032 年的预测值： 9.922亿美元

溶菌酶是生物技术和製药行业的重要组成部分，其全球市场成长主要得益于这种天然抗菌酶的多功能特性。溶菌酶主要来自蛋白、人体分泌物和细菌，是多种应用领域的关键成分，从食品保鲜到药物製剂均有涉及。溶菌酶能够降解细菌细胞壁，使其成为对抗微生物感染和延长多个产业产品保存期限的宝贵资源。

溶菌酶市场提供多种产品类型，包括蛋白来源的溶菌酶、人源溶菌酶和重组溶菌酶，每种产品都符合特定产业的需求。其主要应用领域包括食品饮料、药品、个人保健产品和动物饲料，溶菌酶的天然抗菌特性使其成为合成防腐剂的可持续替代方案。消费者对天然成分日益增长的偏好，以及食品安全和药品品质监管框架的严格要求，使得溶菌酶成为寻求高效天然抗菌解决方案的製造商的首选。生物技术研究的进步、创新的生产方法以及在新兴治疗领域的应用拓展，进一步推动了市场的成长，使其成为一个充满活力且不断发展的领域，具有巨大的商业性潜力。

市场动态

全球溶菌酶市场受多种关键因素驱动，维持强劲成长动能。其中，食品、製药和个人护理行业对天然抗菌剂的需求不断增长是主要驱动因素，因为消费者越来越重视洁净标示产品，而製造商也在寻求合成防腐剂的替代品。食品饮料产业的扩张，尤其是在开发中国家，为溶菌酶在食品保鲜领域的应用创造了巨大的机会。同时，製药业对天然治疗化合物的日益重视，推动了药物製剂和伤口护理应用中对药用级溶菌酶的需求。此外，随着人们对抗生素抗药性的认识不断提高，溶菌酶正逐渐成为一种极具吸引力的替代抗菌剂，大量研究表明其对多种致病微生物有效。

然而，市场仍面临诸多限制因素。溶菌酶萃取和纯化过程的高昂生产成本限制了其在成本敏感型应用领域和新兴市场的应用。特别是，原料蛋清供应有限，给供应链带来了挑战；而复杂的区域性法规则阻碍了市场准入和产品标准化。在某些条件下，溶菌酶的储存稳定性较差，且可能引起敏感族群的过敏反应，这些因素进一步限制了市场扩张。然而，生物技术的进步带来了巨大的机会，重组溶菌酶的生产克服了供应限制和致敏性问题，并有可能降低生产成本。不断扩大的营养保健品市场、在兽医领域的应用拓展、在发展中地区日益增长的应用，以及溶菌酶在多种疾病治疗中的潜在应用，为那些寻求利用溶菌酶多样化功能特性的市场参与企业提供了一条实现盈利增长的道路。

本次调查的主要特点

  • 本报告对全球溶菌酶市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和复合年增长率（%）。
  • 我们将重点介绍各个细分市场的潜在商机，并说明该市场具有吸引力的投资提案矩阵。
  • 该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或核准、市场趋势、区域展望以及主要企业。
  • 本报告根据以下参数对全球溶菌酶市场的主要参与企业进行了分析：公司概况、产品系列、主要亮点、财务表现和策略。
  • 本报告的研究结果将使负责人和经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 这份全球溶菌酶市场报告的目标受众是该行业的各类相关人员，包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
  • 相关人员可以透过全球溶菌酶市场分析中使用的各种策略矩阵轻鬆做出决策。

目录

第一章 研究目标与前提条件

  • 调查目的
  • 先决条件
  • 简称

第二章 市场范围

  • 报告概述
    • 市场定义和范围
  • 执行摘要

第三章：市场动态、监理及趋势分析

  • 市场动态
  • 司机
  • 抑制因素
  • 机会
  • 影响分析
  • 法规环境
  • 产品上市及核准
  • PEST分析
  • 波特分析
  • 併购趋势
  • 产业趋势

4. 2020-2032年全球溶菌酶市场（依治疗用途划分）

  • 抗感染治疗
  • 抗发炎治疗
  • 胃肠道感染疾病管理
  • 呼吸道感染疾病管理
  • 伤口护理和组织修復
  • 免疫调节疗法
  • 其他的

5. 2020-2032年全球溶菌酶市场（依产品类型划分）

  • 重组溶菌酶
  • 天然溶菌酶

6. 2020-2032年全球溶菌酶市场（依剂型划分）

  • 溶菌酶溶液
  • 溶菌酶粉

7. 2020-2032年全球溶菌酶市场依给药途径划分

  • 口服
  • 肠外
  • 外用
  • 其他（鼻内）

8. 2020-2032年全球溶菌酶市场（依製剂类型划分）

  • 单药治疗
  • 联合治疗

9. 2020-2032年全球溶菌酶市场（依最终用户划分）

  • 製药公司
  • 生技公司
  • 医院和诊所
  • 研究所

第十章 全球溶菌酶市场（依通路划分），2020-2032年

  • 在线的
  • 离线

第十一章 全球溶菌酶市场（按地区划分），2020-2032年

  • 北美洲
    • 美国
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲国家
  • 欧洲
    • 德国
    • 英国
    • 西班牙
    • 法国
    • 义大利
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • ASEAN
    • 亚太其他地区
  • 中东
    • GCC
    • 以色列
    • 其他中东国家
  • 非洲
    • 南非
    • 北非
    • 中非

第十二章 竞争格局

  • dsm-firmenich
  • Bioseutica BV
  • WAKO Chemicals
  • Danish Bioscience
  • Qingdao Vland BIoTech
  • Amano Enzyme Inc
  • Lysozyme Corporation
  • Nanning Doing-Higher Bio-Tech
  • Jiangsu Yiming Biological
  • Jiangxi Shineway Pharmaceutical
  • Handary SA
  • Bouwhuis Enthoven
  • AgraFood Ingredients BV
  • Neova Technologies
  • Chr Hansen A/S

第十三章 分析师建议

  • 机会
  • 一致的机会地图

第十四章 参考文献与调查方法

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI9004

Lysozyme Market is estimated to be valued at USD 605.9 Mn in 2025 and is expected to reach USD 992.2 Mn by 2032, growing at a compound annual growth rate (CAGR) of 7.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 605.9 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 7.30% 2032 Value Projection: USD 992.2 Mn

The global lysozyme market represents a significant segment within the biotechnology and pharmaceutical industries, driven by the multifunctional properties of this naturally occurring antimicrobial enzyme. Lysozyme, primarily derived from egg whites, human secretions, and bacterial sources, serves as a crucial component in various applications ranging from food preservation to pharmaceutical formulations. This enzyme's ability to break down bacterial cell walls makes it an invaluable asset in combating microbial infections and extending product shelf life across multiple industries.

The market encompasses diverse product types including egg white lysozyme, human lysozyme, and recombinant lysozyme, each serving specific industrial requirements. Key application sectors include food and beverages, pharmaceuticals, personal care products, and animal feed, where lysozyme's natural antimicrobial properties provide sustainable alternatives to synthetic preservatives. The increasing consumer preference for natural ingredients, coupled with stringent regulatory frameworks governing food safety and pharmaceutical quality, has positioned lysozyme as a preferred choice for manufacturers seeking effective yet natural antimicrobial solutions. The market's growth trajectory is further supported by advancing biotechnology research, innovative production methods, and expanding applications in emerging therapeutic areas, making it a dynamic and evolving sector with substantial commercial potential.

Market Dynamics

The global lysozyme market is propelled by several key drivers that collectively contribute to its robust growth trajectory, with the primary driver being the escalating demand for natural antimicrobial agents across food, pharmaceutical, and personal care industries as consumers increasingly prioritize clean-label products and manufacturers seek alternatives to synthetic preservatives. The expanding food and beverage sector, particularly in developing economies, creates substantial opportunities for lysozyme application in food preservation, while the growing pharmaceutical industry's focus on natural therapeutic compounds drives demand for pharmaceutical-grade lysozyme in drug formulations and wound healing applications. Additionally, the rising awareness of antibiotic resistance has positioned lysozyme as an attractive alternative antimicrobial agent, supported by extensive research demonstrating its efficacy against various pathogenic microorganisms.

However, the market faces significant restraints including the high production costs associated with lysozyme extraction and purification processes, which limit its adoption in cost-sensitive applications and emerging markets. Raw material availability constraints, particularly concerning egg white sources, pose supply chain challenges, while regulatory complexities across different regions create barriers to market entry and product standardization. The limited shelf stability of lysozyme under certain conditions and potential allergenic reactions in sensitive individuals further constrain market expansion. Nevertheless, substantial opportunities emerge from advancing biotechnology enabling recombinant lysozyme production, which addresses supply limitations and allergenicity concerns while potentially reducing production costs. The expanding nutraceutical market, growing applications in veterinary medicine, increasing adoption in developing regions, and potential therapeutic applications in treating various diseases present lucrative growth avenues for market participants seeking to capitalize on lysozyme's diverse functional properties.

Key Features of the Study

  • This report provides in-depth analysis of the global lysozyme market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global lysozyme market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include dsm-firmenich, Bioseutica BV, WAKO Chemicals, Danish Bioscience, Qingdao Vland Biotech, Amano Enzyme Inc, Lysozyme Corporation, Nanning Doing-Higher Bio-Tech, Jiangsu Yiming Biological, Jiangxi Shineway Pharmaceutical, Handary SA, Bouwhuis Enthoven, AgraFood Ingredients BV, Neova Technologies, and Chr Hansen A/S
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global lysozyme market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lysozyme market

Market Segmentation

  • Therapeutic Application Insights (Revenue, USD Mn, 2020 - 2032)
    • Anti-infective Therapies
    • Anti-inflammatory Therapies
    • Gastrointestinal Infection Management
    • Respiratory Infection Management
    • Wound-Healing and Tissue Repair
    • Immunomodulatory Applications
    • Other Therapeutic Uses
  • Product Type Insights (Revenue, USD Mn, 2020 - 2032)
    • Recombinant Lysozyme
    • Natural Lysozyme
  • Form Insights (Revenue, USD Mn, 2020 - 2032)
    • Lysozyme Solution
    • Lysozyme Powder
  • Route of Administration Insights (Revenue, USD Mn, 2020 - 2032)
    • Oral
    • Parenteral
    • Topical
    • Others (Nasal)
  • Formulation Type Insights (Revenue, USD Mn, 2020 - 2032)
    • Monotherapies
    • Combination Therapies
  • End User Insights (Revenue, USD Mn, 2020 - 2032)
    • Pharmaceutical Manufacturers
    • Biotechnology Companies
    • Hospitals and Clinics
    • Research Institutes
  • Distribution Channel Insights (Revenue, USD Mn, 2020 - 2032)
    • Online
    • Offline
  • Regional Insights (Revenue, USD Mn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • dsm-firmenich
    • Bioseutica BV
    • WAKO Chemicals
    • Danish Bioscience
    • Qingdao Vland Biotech
    • Amano Enzyme Inc
    • Lysozyme Corporation
    • Nanning Doing-Higher Bio-Tech
    • Jiangsu Yiming Biological
    • Jiangxi Shineway Pharmaceutical
    • Handary SA
    • Bouwhuis Enthoven
    • AgraFood Ingredients BV
    • Neova Technologies
    • Chr Hansen A/S

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Lysozyme Market, By Therapeutic Application
    • Global Lysozyme Market, By Product Type
    • Global Lysozyme Market, By Form
    • Global Lysozyme Market, By Route of Administration
    • Global Lysozyme Market, By Formulation Type
    • Global Lysozyme Market, By End User
    • Global Lysozyme Market, By Distribution Channel
    • Global Lysozyme Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Lysozyme Market, By Therapeutic Application, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Anti-infective Therapies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Anti-inflammatory Therapies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Gastrointestinal Infection Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Respiratory Infection Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Wound-Healing and Tissue Repair
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Immunomodulatory Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Other Therapeutic Uses
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Lysozyme Market, By Product Type, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Recombinant Lysozyme
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Natural Lysozyme
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Lysozyme Market, By Form, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Lysozyme Solution
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Lysozyme Powder
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Lysozyme Market, By Route of Administration, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Parenteral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Others (Nasal)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Lysozyme Market, By Formulation Type, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Monotherapies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Combination Therapies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Lysozyme Market, By End User, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pharmaceutical Manufacturers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

10. Global Lysozyme Market, By Distribution Channel, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Online
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Offline
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

11. Global Lysozyme Market, By Region, 2020 - 2032, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Form, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Form, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Form, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Form, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Form, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Form, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

12. Competitive Landscape

  • dsm-firmenich
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bioseutica BV
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • WAKO Chemicals
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Danish Bioscience
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Qingdao Vland Biotech
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Amano Enzyme Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lysozyme Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nanning Doing-Higher Bio-Tech
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Jiangsu Yiming Biological
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Jiangxi Shineway Pharmaceutical
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Handary SA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bouwhuis Enthoven
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AgraFood Ingredients BV
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Neova Technologies
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Chr Hansen A/S
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

13. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

14. References and Research Methodology

  • References
  • Research Methodology
  • About us